Search research articles
Contact Us
Filters
Showing results (221-230 of 314) with videos related to
Page
of 32
Sort By:
Genome Biology
|
January 28, 2015
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
Sebastian Kurscheid, Pierre Bady, Davide Sciuscio, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 29, 2021
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns
Martin Glas, Matthew T Ballo, Ze'ev Bomzon, et al.
Cancer Research
|
October 30, 2003
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes
Sophie Godard, Gad Getz, Mauro Delorenzi, et al.
Brain : a Journal of Neurology
|
April 15, 2021
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma
Jack M Shireman, Fatemeh Atashi, Gina Lee, et al.
Neuro-Oncology Advances
|
February 29, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed <i>MGMT</i>-methylated malignant glioma
Riley K Driscoll, Sean B Lyne, David J Voce, et al.
Blood
|
February 21, 2004
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule
Michele Ghielmini, Shu-Fang Hsu Schmitz, Sergio B Cogliatti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2018
Diagnostic value of <sup>18</sup>F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Fabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
Nature Communications
|
February 23, 2024
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
Alexandre Carpentier, Roger Stupp, Adam M Sonabend, et al.
The New England Journal of Medicine
|
March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastoma
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Neuro-Oncology
|
February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
Linda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 314) with videos related to
Sort By:
Page
of 32
Genome Biology
|
January 28, 2015
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
Sebastian Kurscheid, Pierre Bady, Davide Sciuscio, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 29, 2021
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns
Martin Glas, Matthew T Ballo, Ze'ev Bomzon, et al.
Cancer Research
|
October 30, 2003
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes
Sophie Godard, Gad Getz, Mauro Delorenzi, et al.
Brain : a Journal of Neurology
|
April 15, 2021
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma
Jack M Shireman, Fatemeh Atashi, Gina Lee, et al.
Neuro-Oncology Advances
|
February 29, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed <i>MGMT</i>-methylated malignant glioma
Riley K Driscoll, Sean B Lyne, David J Voce, et al.
Blood
|
February 21, 2004
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule
Michele Ghielmini, Shu-Fang Hsu Schmitz, Sergio B Cogliatti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2018
Diagnostic value of <sup>18</sup>F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Fabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
Nature Communications
|
February 23, 2024
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
Alexandre Carpentier, Roger Stupp, Adam M Sonabend, et al.
The New England Journal of Medicine
|
March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastoma
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Neuro-Oncology
|
February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
Linda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
Page
of 32